Klont (Metronidazole)

Metronidazole enters anaerobic bacteria and protozoa and is reduced to reactive nitro radicals. These radicals bind to DNA, causing strand breaks and inhibiting nucleic acid synthesis, which ultimately leads to cell death while sparing most aerobic cells.

The specific dose of Klont is determined by the prescribing clinician based on the infection being treated, patient age, weight, renal and hepatic function, and other clinical factors. Patients should follow the exact regimen provided by their healthcare professional.

Metronidazole is classified as Pregnancy Category B, indicating that animal studies have not shown risk but there are limited human data. It may be used during pregnancy only if the potential benefit justifies the risk. Caution is advised while breastfeeding; a healthcare provider should evaluate the situation.

To request Klont, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Compared with alternatives such as tinidazole, metronidazole (Klont) has a similar spectrum against anaerobic bacteria and protozoa but differs in half‑life and dosing frequency. Metronidazole is often chosen for its extensive clinical experience, lower cost, and established safety profile, while tinidazole may require fewer doses for some infections.

Klont should be stored below 25 °C in a dry place, kept in its original packaging to protect from moisture and light. Do not store in bathrooms or near heat sources, and keep out of reach of children.

Klont is taken orally, usually with food or a full glass of water to reduce gastrointestinal irritation. The tablet should be swallowed whole and not crushed or chewed unless specifically instructed by a healthcare professional.

Serious risks include seizures, peripheral neuropathy, and severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience neurological symptoms, rash, swelling, or difficulty breathing.

Klont is contraindicated in individuals with a known hypersensitivity to metronidazole or other nitroimidazole compounds. It should also be avoided in patients with severe hepatic impairment unless benefits outweigh risks, and in those who are currently consuming alcohol.